○Specchio Nicola1, Angela Schulz2, Paul Gissen3, De Los Emily Reyes4, Ruth Williams5, Heather Cahan6, Peter Slasor6, David Jacoby6 (1.Bambino Gesu Childrens Hospital, IRCCS, Rome, Italy, 2.University Medical Center Hamburg-Eppendorf, Hamburg, Germany, 3.Great Ormond Street Hospital for Children, London, United Kingdom, 4.Nationwide Children s Hospital, The Ohio State University, Columbus, OH, United States, 5.Guys and St Thomas NHS Foundation Trust, London, United Kingdom, 6.BioMarin Pharmaceutical Inc., Novato, CA, United States)
Session information
English Session
metabolic diseases
[E1] English Session 1
neurodegenerative disease / metabolic disease
Thu. Jun 15, 2017 11:20 AM - 12:20 PM Room No.2 (6F Sub Hall)
Chair:Akira Oka (Department of Pediatrics, The University of Tokyo, Tokyo, Japan) Norio Sakai(Division of Health Science, Osaka University Graduate School of Medicine, Suita, Japan)
○Yoshikatsu Eto1, Takashi Miyajima2, Junko Igarashi2, Keiko Akiyama1, Hiroko Yanagisawa1, Arif Hossain1, Kaoru Eto3, Takeo Iwamoto4 (1.Advanced Clinical Research Center, Institute of Neurological Disorders, Kanagawa, Japan, 2.AngesMG Institute for Rare Diseases, 3.Tokyo Women's Medical University, Department of Pediatrics, Tokyo, Japan, 4.Tokyo Jikei University School of Medicine, Core Central Laboratory, Tokyo, Japan)
○Makito Hirano1,2, Kazumasa Saigoh2, Yusaku Nakamura1, Susumu Kusunoki2 (1.Department of Neurology, Sakai Hospital Kindai University Faculty of Medicine,Osaka,Japan, 2.Department of Neurology, Kindai University Facutly of Medicine, Osaka, Japan)
○Karin Kojima1, Akihiko Miyauchi1, Takeshi Nakajima2, Sayaka Asari3, Hiroaki Mizukami4, Hitoshi Osaka1, Shin-ichi Muramatsu5, Takanori Yamagata1 (1.The Department of Pediatrics, Jichi Medical University, Tochigi, Japan, 2.Department of Neurosurgery, Jichi Medical University, Shimotsuke-shi, Tochigi, Japan, 3.Department of Neurology, Saitama Medical Center, Jichi Medical University, Saitama, Japan, 4.Division of Genetic Therapeutics, Jichi Medical University, Shimotsuke, Tochigi, Japan, 5.Department of Neurology, Jichi Medical University, Shimotsuke, Tochigi, Japan, 6.Center for Gene & Cell Therapy, The Institute of Medical Science, The University of Tokyo, Japan)
○Saito Kayoko1, Nancy Kuntz2, Wildon Farwell3, Zhenshao John Zhong3, Peng Sun3, Sarah Gheuens3, Eugene Schneider4, Richard Finkel(endear Study Group)5 (1.Tokyo Women’s Medical University, Institute of Medical Genetics,Tokyo, Japan, 2.Division of Neurology, Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL, USA, 3.Biogen, Cambridge, MA, USA, 4.Ionis Pharmaceuticals Inc., Carlsbad, CA, USA, 5.Division of Neurology, Department of Pediatrics, Nemours Children’s Hospital, Orlando, FL, USA)
○Shohei Kusabiraki, Akihiko Ishiyama, Eri Takeshita, Yuko Shimizu-motohashi, Takashi Saito, Hirofumi Komaki, Eiji Nakagawa, Kenji Sugai, Masayuki Sasaki (Department of Child Neurology, National Center of Neurology and Psychiatry, Tokyo, Japan)